Z Squared Inc. 8-K

What Happened

• Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.) filed an 8-K on June 29, 2026 announcing it completed an advance under its Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd.
• On June 26, 2026 the company issued 1,302,806 shares of common stock at $11.8351 per share, generating aggregate gross proceeds of $15,418,839.29. The company also announced completion of its use of the SEPA.
• The company confirmed its inclusion in the Russell 3000® Index and the Russell 2000® Index following FTSE Russell’s 2026 annual reconstitution, effective after the close of trading on June 26, 2026.

Key Details

• SEPA counterparty: YA II PN, Ltd.; original SEPA date: November 1, 2024 (up to $20,000,000 capacity).
• Shares issued: 1,302,806; price per share: $11.8351; gross proceeds: $15,418,839.29.
• Securities sold to YA II PN, Ltd. were offered under Section 4(a)(2) exemption; YA II PN’s resale of the shares is registered on the company’s Form S-1 (File No. 333-284230).
• Company furnished press releases on June 29, 2026 about the SEPA completion and Russell index inclusions.

Why It Matters

• The SEPA advance provided an immediate cash infusion (~$15.4M) which can support operations, development programs or other corporate needs without a public registered offering.
• Inclusion in the Russell 3000 and Russell 2000 can increase visibility and may lead to passive index fund ownership, potentially affecting liquidity and shareholder composition.
• Investors should note the source and terms of funding (private placement to an institutional buyer, resale registered under S-1) and the timing of the index inclusion (effective after market close June 26, 2026).